Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2001 3
2002 13
2003 16
2004 17
2005 13
2006 14
2007 19
2008 11
2009 14
2010 6
2011 4
2012 4
2013 13
2014 9
2015 4
2016 5
2017 4
2019 4
2020 4
2022 3
2024 3
2025 2
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

172 results

Results by year

Filters applied: . Clear all
Page 1
Comparative Efficacy of Mometasone Nasal Spray Combined with Different Doses of Desloratadine, and Montelukast in Childhood Allergic Rhinitis: A Randomized Clinical Trial.
Ghanbari N, Eftekhari K, Samadzadeh-Mamaghani M, Sedighiyan M, Diaz DN, Shafiei A. Ghanbari N, et al. Iran J Allergy Asthma Immunol. 2024 Jul 27;23(4):366-373. doi: 10.18502/ijaai.v23i4.16211. Iran J Allergy Asthma Immunol. 2024. PMID: 39549290 Free article. Clinical Trial.
In addition to mometasone, each group received one of the following drugs or drug combinations: daily desloratadine, twice daily desloratadine, montelukast, or a combination of desloratadine and montelukast. ...The reduction of nasal congestion score and tota …
In addition to mometasone, each group received one of the following drugs or drug combinations: daily desloratadine, twice daily d …
Oral isotretinoin with desloratadine compared with oral isotretinoin alone in the treatment of moderate to severe acne: a randomized, assessor-blinded study.
Hazarika N, Yadav P, Bagri M, Chandrasekaran D, Bhatia R. Hazarika N, et al. Int J Dermatol. 2024 Jul;63(7):929-935. doi: 10.1111/ijd.17129. Epub 2024 Mar 28. Int J Dermatol. 2024. PMID: 38546101 Clinical Trial.
BACKGROUND: Our aim was to measure the effectiveness of oral isotretinoin with desloratadine compared with oral isotretinoin alone in treating moderate to severe acne at a tertiary care teaching hospital in North India. ...A low-dose oral isotretinoin at a dose of 0.3 mg/k …
BACKGROUND: Our aim was to measure the effectiveness of oral isotretinoin with desloratadine compared with oral isotretinoin alone in …
Association between desloratadine and prednisolone in the treatment of children with acute symptoms of allergic rhinitis: a double-blind, randomized and controlled clinical trial.
Wandalsen GF, Miranda C, Ensina LF, Sano F, Amazonas RB, Silva JMD, Solé D. Wandalsen GF, et al. Braz J Otorhinolaryngol. 2017 Nov-Dec;83(6):633-639. doi: 10.1016/j.bjorl.2016.08.009. Epub 2016 Sep 13. Braz J Otorhinolaryngol. 2017. PMID: 27670203 Free PMC article. Clinical Trial.
OBJECTIVE: To evaluate safety and efficacy of desloratadine plus prednisolone in the treatment of acute symptoms of children (2-12 years) with allergic rhinitis, and to compare it to dexchlorpheniramine plus betamethasone. ...Ninety-six children of the dexchlorpheniramine …
OBJECTIVE: To evaluate safety and efficacy of desloratadine plus prednisolone in the treatment of acute symptoms of children (2-12 ye …
Pharmacokinetics of desloratadine in children between 2 and 11 years of age.
Gupta S, Khalilieh S, Kantesaria B, Banfield C. Gupta S, et al. Br J Clin Pharmacol. 2007 May;63(5):534-40. doi: 10.1111/j.1365-2125.2006.02810.x. Br J Clin Pharmacol. 2007. PMID: 17488362 Free PMC article. Clinical Trial.
CONCLUSIONS: Single doses of desloratadine syrup (1.25 and 2.5 mg) were well tolerated in children 2-5 and 6-11 years old. Desloratadine exposure in children appears to be similar to that observed in adults, in whom efficacy has been established....
CONCLUSIONS: Single doses of desloratadine syrup (1.25 and 2.5 mg) were well tolerated in children 2-5 and 6-11 years old. Deslora …
Efficacy and safety of combined oral isotretinoin and desloratadine vs. isotretinoin alone in acne vulgaris: a comparative study.
El-Ghareeb MI, Kandeel AH, Khayrullah NM. El-Ghareeb MI, et al. Arch Dermatol Res. 2025 Apr 10;317(1):689. doi: 10.1007/s00403-025-04145-7. Arch Dermatol Res. 2025. PMID: 40204949 Clinical Trial.
A combination of desloratadine (DESL) and oral isotretinoin (ISO) may enhance efficacy and reduce the side effects of ISO, particularly those affecting the skin and mucous membranes. ...
A combination of desloratadine (DESL) and oral isotretinoin (ISO) may enhance efficacy and reduce the side effects of ISO, particular …
H1-Antihistamine Premedication in NSAID-Associated Urticaria.
Trautmann A, Anders D, Stoevesandt J. Trautmann A, et al. J Allergy Clin Immunol Pract. 2016 Nov-Dec;4(6):1205-1212. doi: 10.1016/j.jaip.2016.05.018. Epub 2016 Jun 30. J Allergy Clin Immunol Pract. 2016. PMID: 27372601 Clinical Trial.
METHODS: Data of 21 patients with NSAID-induced or NSAID-exacerbated urticaria who underwent single dose NSAID provocation 30 minutes after premedication with 5 mg desloratadine were retrospectively evaluated. RESULTS: After H(1)-antihistamine premedication, 17 patients to …
METHODS: Data of 21 patients with NSAID-induced or NSAID-exacerbated urticaria who underwent single dose NSAID provocation 30 minutes after …
Bilastine as a potential treatment in allergic rhinitis.
Kowal K, DuBuske L. Kowal K, et al. Am J Rhinol Allergy. 2014 Jul-Aug;28(4):312-6. doi: 10.2500/ajra.2014.28.4049. Am J Rhinol Allergy. 2014. PMID: 25197918 Clinical Trial.
Efficacy of bilastine in therapy of allergic rhinitis patients has been documented in several large controlled clinical trials showing bilastine being at least as effective as cetirizine or desloratadine. No significant suppressive effect on central nervous system could be …
Efficacy of bilastine in therapy of allergic rhinitis patients has been documented in several large controlled clinical trials showing bilas …
Pharmacokinetics and bioequivalence study of a generic desloratadine tablet formulation in healthy male volunteers.
Yeh GC, Deng ST, Lo CY, Chiang PS, Hsiong CH. Yeh GC, et al. Arzneimittelforschung. 2004;54(3):166-70. doi: 10.1055/s-0031-1296954. Arzneimittelforschung. 2004. PMID: 15112863 Clinical Trial.
A single oral dose (10 mg/2 tablets) of desloratadine was administered to 8 healthy young Chinese males in a completely double-blind cross-over design with a two-week washout period between each dose. ...By ANOVA, 90% confidence interval, Mann-Whitney test, and paired t-te …
A single oral dose (10 mg/2 tablets) of desloratadine was administered to 8 healthy young Chinese males in a completely double-blind …
Single-dose desloratadine and montelukast and allergen-induced late airway responses.
Davis BE, Illamperuma C, Gauvreau GM, Watson RM, O'Byrne PM, Deschesnes F, Boulet LP, Cockcroft DW. Davis BE, et al. Eur Respir J. 2009 Jun;33(6):1302-8. doi: 10.1183/09031936.00169008. Epub 2009 Jan 22. Eur Respir J. 2009. PMID: 19164343 Free article. Clinical Trial.
Montelukast and desloratadine synergistically inhibit the allergen-induced early asthmatic response. Montelukast also suppresses the allergen-induced late asthmatic response, but there are no reports on the effect of desloratadine or the combination on the allergen- …
Montelukast and desloratadine synergistically inhibit the allergen-induced early asthmatic response. Montelukast also suppresses the …
Clinical Efficacy of Vitamin D3 Adjuvant Therapy in Allergic Rhinitis: A Randomized Controlled Trial.
Liu X, Liu X, Ren Y, Yang H, Sun X, Huang H. Liu X, et al. Iran J Immunol. 2020 Dec;17(4):283-291. doi: 10.22034/iji.2020.84336.1652. Iran J Immunol. 2020. PMID: 33382385 Free article. Clinical Trial.
The patients with potential eligible AR were randomly allocated to intervention with desloratadine citrate disodium (DCD, 8.8 mg/day) without and with vitamin D3 nasal drops (1.5 106 IU, once/week) for four weeks. ...
The patients with potential eligible AR were randomly allocated to intervention with desloratadine citrate disodium (DCD, 8.8 mg/day) …
172 results